WeVote
Log In
Back
Bill
Sponsor avatar

BILL • US HOUSE
HR 1492

To amend title XI of the Social Security Act to equalize the negotiation period between small-molecule and biologic candidates under the Drug Price Negotiation Program.

119th Congress
Introduced by Rick Allen, Mark Amodei, Troy Balderson and 56 other co-sponsors

HR 1492 extends drug price negotiations for biologics from 7 to 11 years, aiming to lower costs for consumers and reshape pricing strategies for pharmaceutical companies.

Introduced in House
0
0
0
0
Bill Summary • HR 1492
Analyzing...

Hi! I'm your AI assistant for HR 1492. I can help you understand its provisions, impacts, and answer any questions.

Key Provisions Impacts Timeline
Sign in to chat